Actively Recruiting
Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer
Led by Fudan University · Updated on 2024-03-21
30
Participants Needed
1
Research Sites
200 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy of gemcitabine and nab-paclitaxel venous injection plus transcatheter arterial infusion to Patients with Advanced Pancreatic Cancer.
CONDITIONS
Official Title
Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Ability to understand and willing to sign informed consent
- Age between 18 and 80 years
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
- Histologically or cytologically confirmed advanced pancreatic adenocarcinoma
- Primary pancreatic cancer without prior major anti-cancer treatments
- Locally advanced or metastatic pancreatic cancer
- At least one measurable lesion according to RECIST criteria
- Expected survival of at least 3 months
- Adequate organ function based on laboratory blood tests
- Willingness and ability to comply with study procedures
You will not qualify if you...
- Pregnant or nursing women
- Previous treatment with anti-tumor chemotherapy, radiotherapy, or other treatments
- Diagnosis of pancreatic cancer other than adenocarcinoma
- Inflammation of the digestive tract (e.g., pancreatitis, cholecystitis, cholangitis)
- Severe uncontrollable diseases affecting study compliance or result interpretation
- History of cardiovascular or cerebrovascular accidents
- Allergy to study drugs
- Other serious illnesses that may affect treatment safety as judged by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shanghai Cancer Center
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
Y
Ying Yang, MD
CONTACT
G
Guopei Luo, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here